CTMS Face to Face February caBIG ® Biomedical Research Business Architecture Model Real World Use of the BAM – its not just a bunch of bubbles . Michele Ehlman Essex Management February 4 th 2010. Agenda. Welcome Biomedical Research Architecture Model (BAM) Overview Purpose of a BAM
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
CTMS Face to FaceFebruary caBIG® Biomedical Research Business Architecture ModelReal World Use of the BAM – its not just a bunch of bubbles
February 4th 2010
"A blueprint of the enterprise that provides a common understanding of the organization and is used to align strategic objectives and tactical demands."
Object Management Group, Business Architecture Working Group, Definition
The Biomedical Research Architecture Model (BAM) is a blueprint of biomedical research. It documents a common understanding of the information, “what, who, how, where and when,” necessary to realize research, so that it is accessible to someone, who is not directly involved in research to align strategic objectives and meet tactical demands.
Modeling the key goals and workflows of research provides a starting point allowing us to organize the use cases that represent the many aspects and flavors of Biomedical Research… because…
By utilizing the pieces of the BAM we are able to identify the patterns that represent the many aspects of Biomedical Research.
Pg 39, SAEAF – Services –Aware Enterprise Architecture Framework handbook, January 19th 2010
with the BAM in their
To provide training to non clinicians and scientists to help them understand the research process
A scientist is trying to identify a new genetic biomarker for HER2/neu negative stage I breast cancer patients. Using a caGrid-aware client, the scientist queries for HER2/neu negative tissue specimens of Stage I breast cancer patients
* All four (4) are required to have a clear understanding of the process
The BAM is currently being used by Cancer Electronic Health Records (caEHR) team, Clinical Trials Reporting Program (CTRP) and the Protocol Lifecycle Tracking (PLT) team to identify business requirements for current/future system development.
Develop comprehensive and integrated Enterprise Use Cases for the Population Sciences and Cancer Control Community
Gene Kraus, Population Sciences Enterprise Use Cases Group, November 19th 2009
Sharon Elcombe – CTMS SME, Mayo Clinic
Bob Morrell – CTMS SME, Wake Forrest
Brian McIndoe – CBIIT Enterprise Services, Ekagra Software
Paul Davis – CBIIT Analyst, Essex Management
Diane Paul – Patient Advocate
Elaine Freund, ICR Workspace Lead, 3rd Millennium
Michele Ehlman email@example.com 860-235-8125
The caBIG® Biomedical Research Business Architecture Model is available through https://cabig.nci.nih.gov/workspaces/CTMS/workspaces/CTMS/Business_Arch_Model
Additional information is also available at https://cabig-kc.nci.nih.gov/CTMS/KC/index.php/BAM
For more information about the caBIG® Clinical Trials Management Systems Workspace, please visit https://cabig.nci.nih.gov/workspaces/CTMS/
NCI caBIG® Knowledge Center Website
Biomedical Research BAM page: